LOS ANGELES, CA | January 31, 2017

Hueston Hennigan Halts Deportation of California Resident to Sudan

When the recent White House Executive Order on immigration left Areej Ali, 33, not only stranded in Saudi Arabia last Saturday, but poised for deportation to Sudan—a country she barely knew—her family contacted Hueston Hennigan. Led by Pro Bono Coordinator Courtney Black, the firm sprang into action, preparing a letter to authorities in Saudi Arabia explaining that as a Green Card holder, Ali was entitled to return to the United States, her home for the past 26 years. Saudi authorities reversed themselves and allowed Ali to return home. We are thrilled for Ali and her family, and we are proud of all the attorneys, at our firm and across the country, who have helped ensure that the law is followed for individuals affected by the Executive Order. 

LOS ANGELES, CA | January 30, 2017

Arbitrator Vindicates Former Bar President

In a recent decision, JAMS arbitrator Edward A. Infante granted a motion for summary judgment brought by former State Bar President Craig Holden, upholding his assertion that he never engaged in retaliatory behavior or conspired to have former Bar Executive Director Joseph Dunn fired. "We appreciate the arbitrator's thoughtful, reasoned opinion," said Moez Kaba, who represented Mr. Holden. "Mr. Holden always maintained that he acted properly and with integrity, and we are happy that he can now move on from this matter."

LOS ANGELES, CA | January 11, 2017

Amgen Beats Decade-Old Investor Suit

By Bonnie Eslinger Law360, Los Angeles -- A California judge Tuesday dismissed a decade-old action claiming Amgen Inc.’s board caused more than $1 billion in damages by overseeing an off-label drug marketing scheme, saying the shareholder failed to make a demand on the officials to instigate litigation before filing her suit.  Shareholder Judy Durgin’s suit, brought in May 2007, relates to allegedly misleading statements the pharmaceutical giant made about off-label uses for two of its drugs, Aranesp and Epogen. In 2012, the company pled guilty in federal court to misbranding Aranesp and agreed to a combined $762 million civil and criminal payout to resolve the allegations about its sales and marketing practices. It also paid tens of millions of dollars to resolve state claims and an investor class action. In his Tuesday ruling, U.S. District Judge Philip Gutierrez said Durgin also failed to adequately allege, with the legally required specificity, that she didn’t make a prelitigation demand on the board because to do so would have been “futile.” He also noted that she asked the court to introduce into evidence 24 new exhibits in support of her complaint.

LOS ANGELES, CA | January 06, 2017

Hueston Hennigan Announces Firm Promotions

Hueston Hennigan is pleased to announce the promotion of three senior associates to the position of counsel: Andrew Walsh, Padraic Foran, and Steven Feldman. Mr. Walsh: Mr. Walsh, a key member of the firm’s environmental litigation practice, has consistently demonstrated skill and innovative leadership on a range of matters, said Partner John Hueston. “Andrew has done remarkable work through the years,” he said. “He does not avoid any challenge, no matter how legally novel or difficult.” Mr. Foran: “Pad is an extraordinarily gifted lawyer; his writing is exceptional, and his contributions as a firm citizen are outstanding. He has become a go-to lawyer for many of our clients on their most challenging cases.” said Partner Moez Kaba in announcing Mr. Foran’s promotion. Mr. Feldman: Of Mr. Feldman, Partner Alison Plessman noted his dedication to clients and his strategic thinking. “What makes him stand out is that you can hand him something, and by the time he’s done, it’s poised for success. He has thought th

LOS ANGELES, CA | December 21, 2016

The Art of the Trial: Cross-Examination

Hueston Hennigan's "Art of the Trial" series, authored by the firm's partners and published in the Los Angeles Daily Journal, continues with a new chapter by Marshall A. Camp.  In "Art of the Trial: Cross-Examination", Mr. Camp shares his thoughts on the keys to an effective cross-examination.